Modulators of cxcr7

The present invention provides compounds of Formula I, or a pharmaceutically acceptable salt, hydrate or N- oxide thereof, and may be used in combination therapy CXCR7 CXCR7 least partially dependent on disease activity. Thus, in some other aspects, the present invention provides a composition comprising a pharmaceutically acceptable excipient mixture is mixed with one or more of the above compounds.